Kelly, R. J., Lam, V. K., Paulson, A. S., McCollum, A. D., Kitchens, B. L., Abushahin, L. I., Sherry, C., Anees, M., LaFramboise, W., Schwartz, R. S., Goel, A., Zheng, P., Wagner, P., Bartlett, D. L., Raj, M. S., Anagnostou, V., Zaidi, A. H. (2025). Multicenter phase I/II study of abemaciclib and ramucirumab in metastatic gastroesophageal adenocarcinoma (GEA): CDK4/6 and cyclin D1 alterations as a predictor of response and survival.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4063